By
Eugene Braunwald, MD, Distinguished Hersey Professor of Medicine, Harvard Medical School; Chairman, TIMI Study Group, Brigham and Women's Hospital, Boston, MA
Description
Biomarkers — which may be enzymes, hormones, biologic substances, or other markers of cardiac stress and malfunction — appear to have
growing clinical importance in heart failure. Many biomarkers appear to provide important information about the cause of heart failure
or the identification of those at risk for heart failure or appear to be useful in risk stratification, in the diagnosis of heart failure,
or in monitoring therapy. This issue discusses the current and potential future role of biomarkers and includes articles that explore
individual biomarkers in depth.
Included in series
The Clinics: Internal Medicine
